Vaytsorb (Tablets) Instructions for Use

Marketing Authorization Holder

Nizhpharm JSC (Russia)

Manufactured By

PharmVILAR NPO, LLC (Russia)

Contact Information

NIZHPHARM group of companies (Russia)

Active Substance

Colloidal silicon dioxide (USNF The United States "National Formulaty")

Dosage Form

Vaytsorb

Tablets 0.36 g: 10 or 30 pcs.

Dosage Form, Packaging, and Product Composition

Dosage form: tablets.

Composition: Colloidal silicon dioxide, microcrystalline cellulose (filler), potato starch (filler), magnesium stearate (glidant).

Adequate silicon intake level is from 24%-30% to 65%-81% (does not exceed the upper permissible intake level).

Packaging: 10 tablets in a blister, 1 or 3 blisters in a cardboard pack.

Properties

Colloidal silicon dioxide represents spherically shaped granules produced using a special technology. It possesses high sorption capacity (the amount of substance a sorbent can absorb per unit of its mass). The average granule size is about 30 µm. Each colloidal silicon dioxide granule acts as a micro-container, absorbing toxic and poisonous components, both dissolved and undissolved in fluid.

As a polysorbent, granulated Colloidal silicon dioxide binds via adsorption and removes from the body

• Toxins entering from outside (including waste products of pathogenic microorganisms),
• Food and bacterial allergens,
• Poisons, chemical substances (of synthetic and natural origin),
• Alcohol,
• Products of protein, lipid, and other metabolism,
• Radionuclides.

Colloidal silicon dioxide helps reduce the metabolic load on detoxification organs (primarily the liver and kidneys), eliminate the imbalance of biologically active substances in the body, correct metabolic processes and immune status, and improve lipid metabolism parameters such as cholesterol, triglyceride, and total lipid levels.

As a source of silicon, colloidal silicon dioxide replenishes the body’s needs for this essential trace element.

Silicon is a trace element constantly present in the human body. Silicon plays an important role in the bone tissue mineralization process; it is necessary for maintaining the elasticity of arterial walls, has a positive effect on immunity, and slows down the aging processes in human body tissues.

The microcrystalline cellulose (MCC) present in the product’s composition enhances the adsorptive and detoxification properties of Vaytsorb.

The components of Vaytsorb contribute to the elimination of toxins of various origins and prevent the development of silicon deficiency in the body.

Scope of Application

Of the Vaytsorb product

As a dietary supplement – a source of silicon and a polysorbent.

ICD codes

Dosage Regimen

Adults: 1-2 tablets 3-4 times a day with meals, taken with water.

Consult a doctor before use.

Contraindications

• Individual intolerance to the product’s components;
• Pregnancy;
• Breastfeeding;
• Gastric and duodenal ulcer in the acute phase.

Use during pregnancy and lactation

Use during pregnancy and breastfeeding is contraindicated.

Special instructions

Dietary supplement, not a medicine.

Dispensing Status

Available to the public through pharmacy networks and specialized stores, departments of the retail chain.

Storage Conditions

Store in a dry place, protected from light and out of reach of children, at a temperature not exceeding 25°C (77°F).

Shelf Life

Shelf life – 3 years.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.